FACIT (Fight Against Cancer Innovation Trust) — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Xpan IncAug 2022
BiotechNobleton
Zaid Atto(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.